Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 2
1(50.0%)
Phase 3
1(50.0%)
2Total
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07054073Recruiting

HCMR Re-Imaging Study

Role: collaborator

NCT05003817Phase 3Active Not Recruiting

Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventricular Unloading

Role: collaborator

NCT03615040Phase 2Completed

Anti-ST2 (MSTT1041A) in COPD (COPD-ST2OP)

Role: collaborator

All 3 trials loaded